Lee, S.-H.; Son, Y.; Jang, H.; Kim, H.-Y.; Kim, K.S.; Lee, H.-S.; Lee, H.-J.
Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis. Int. J. Mol. Sci. 2026, 27, 2676.
https://doi.org/10.3390/ijms27062676
AMA Style
Lee S-H, Son Y, Jang H, Kim H-Y, Kim KS, Lee H-S, Lee H-J.
Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis. International Journal of Molecular Sciences. 2026; 27(6):2676.
https://doi.org/10.3390/ijms27062676
Chicago/Turabian Style
Lee, Soo-Ho, Yeonghoon Son, Hyosun Jang, Hyun-Yong Kim, Kwang Seok Kim, Hyun-Shik Lee, and Hae-June Lee.
2026. "Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis" International Journal of Molecular Sciences 27, no. 6: 2676.
https://doi.org/10.3390/ijms27062676
APA Style
Lee, S.-H., Son, Y., Jang, H., Kim, H.-Y., Kim, K. S., Lee, H.-S., & Lee, H.-J.
(2026). Fluoxetine Repurposing Mitigates Alzheimer’s Disease Pathology via the GSK3β–CREB–ADAM10 Axis. International Journal of Molecular Sciences, 27(6), 2676.
https://doi.org/10.3390/ijms27062676